Pharma major Novartis falls 9% after three drug trial setbacks
Novartis shares tanked on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial.
Finance & markets
Global markets keep shrugging off shocks. Here's what could break that streak, according to HSBC
Global markets have shrugged off a barrage of shocks in recent years, but HSBC sees several developments that could eventually end that streak.
Cholesterol drug setback casts doubt over multibillion-dollar race
Novartis' failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry's biggest drug races and rival treatments from U.S. heavyweights Amgen and Eli Lilly.
China's imports in August miss estimates as exports pick up pace amid calls for rebalancing trade
China's trade growth picked up in August, though imports missed expectations, a sign that domestic demand remains tepid as the world's second-largest economy faces mounting pressure to rebalance trade.
Nvidia supplier Wistron's shares drop after it announces $1.5 billion global stock sale
Shares of Taiwan's Wistron Corporation fell more than 6% Tuesday after the Nvidia supplier priced a $1.47 billion global depositary receipt offering to fund raw material purchases.
Oil extends gains as renewed Mideast hostilities raise worries of prolonged conflict
Oil prices extended gains Tuesday, rising for a third straight day, and hovering at six-week highs on worries over escalating Mideast tensions after the U.S. and Iran traded strikes over the weekend.
Iran foreign ministry takes aim at Canada for support of U.S. actions in Strait of Hormuz
Iran hit out at Canada for supporting U.S. actions in the Strait of Hormuz, calling Ottawa's moves "a display of strategic confusion and submission to intimidation." In a post on X, Tehran's Foreign Ministry spokesperso…
Trump says Bombardier can't sell in U.S. unless Canada aerospace giant builds there
President Donald Trump on Monday said Bombardier, a Canadian airplane manufacturer, must build its products in the U.S. in order to keep selling in the American market.
Volkswagen finds defence future for German plant amid major overhaul
A data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
4 Reasons to Add Host Hotels Stock to Your Portfolio Now
Host Hotels & Resorts Inc. HST boasts a portfolio of luxury and upper-upscale hotels located across top U.S. markets and the Sunbelt region. The improved group travel and business transient demand for the company’s well…
Dell & 2 Momentum Stocks to Buy Now for Explosive Upside
Volatility has returned in September 2026, a month that has traditionally been one of the weakest for the stock market, making it difficult for investors to identify stocks capable of delivering outsized gains. However,…
4 Leisure & Recreation Stocks Worth Watching Despite Industry Pressure
The Zacks Leisure and Recreation Products industry is facing pressure from cautious consumer spending, higher tariffs, elevated input costs and economic uncertainty. These headwinds could weigh on demand and margins, pa…
Procter & Gamble Margins Under Pressure: Time to Stay Cautious?
The Procter & Gamble Company PG continues to benefit from its well-established portfolio of consumer brands, extensive global presence and strong productivity and pricing initiatives. However, margin pressure remains a …
Broadcom Drops 10% in 3 Months: Buy, Sell or Hold the Stock?
Broadcom AVGO shares have dropped 9.7% over the past three months, underperforming the broader Zacks Computer and Technology sector’s return of 0.9%. The company’s shares have been suffering from margin pressure from th…
'Ah! Rejected, yet again': How this 45-year-old turned his 'demoralizing' job search into a one-man show
"It's 12:38 in the morning, and I just got an email about one of my job applications," he said.
DELL Expands Consumer PC Reach: Can It Challenge HPQ & AAPL?
Dell Technologies DELL is benefiting from improving demand across its Client Solutions Group (CSG), supported by PC refresh activity and an expanding consumer portfolio. The company recently introduced the Dell 14S, an …
Needham Initiates Coverage of Babcock & Wilcox Enterprises, Inc. - Corporate Bond at Buy
Fintel reports that on August 31, 2026, Needham initiated coverage of Babcock & Wilcox Enterprises, Inc. - Corporate Bond (NYSE:BWNB) with a Buy recommendation.
PANW Surges 102% in 6 Months: Should You Buy, Sell or Hold the Stock?
Palo Alto Networks PANW shares have soared 101.8% in the past six months, outperforming the Zacks Security industry’s 85% growth. The stock has outperformed other industry peers as well, including Qualys Inc. QLYS, Zsca…
Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?
Aehr Test Systems, Inc. AEHR is gaining traction in AI semiconductor testing as AI chips become more complex and costly. Its wafer-level burn-in technology allows manufacturers to screen devices before packaging, helpin…
NVIDIA's Hugging Face Buyout: Can It Further Strengthen AI Dominance?
NVIDIA Corporation’s NVDA proposed $12.93 billion acquisition of Hugging Face could strengthen its AI leadership by expanding its reach beyond chips and into the open-model ecosystem. The deal would give NVIDIA access t…
PBF Energy Rises 168% in a Year: Is This the Right Time to Buy?
PBF Energy PBF is a well-known refining firm in the United States that operates a diverse, highly complex refining network with large-scale processing capacity. It operates six refineries: Delaware City Refinery, Paulsb…
Greenland welcomes major funding boost from EU amid Trump’s annexation threats
European Commission President Ursula von der Leyen on Monday announced a fresh funding boost for Greenland, seeking to shore up Arctic ties with the self-governing Danish territory amid U.S. President Donald Trump's ann…
Oil prices rise to 6-week high after Iran and U.S. trade blows, Saudi Aramco facilities reportedly hit
Oil prices rose to a six-week high on Monday as the U.S. and Iran traded strikes over the weekend, ratcheting up tensions in the Middle East.
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?
Shares of Capricor Therapeutics CAPR have surged 144% over the past month. The rally reflects a combination of encouraging phase III data for its lead cell therapy candidate, deramiocel, in Duchenne muscular dystrophy (…